Nicholas D Peterson Selected Research

Pyrazinamide

1/2017	Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
12/2014	Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas D Peterson Research Topics

Disease

5	Tuberculosis (Tuberculoses) 01/2017 - 12/2014
4	Infections 10/2023 - 10/2018
4	Bacterial Infections (Bacterial Infection) 10/2023 - 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2023

Drug/Important Bio-Agent (IBA)

2	Pyrazinamide FDA LinkGeneric 01/2017 - 12/2014
1	SphingolipidsIBA 10/2023
1	EnzymesIBA 10/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	BiguanidesIBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	CholesterolIBA 01/2022
1	NAD+ Nucleosidase (NAD(P) Nucleosidase)IBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Monounsaturated Fatty AcidsIBA 01/2019
1	Oleic Acid (Oleate)IBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	OligonucleotidesIBA 01/2017
1	pyrazinamide deamidaseIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Green Fluorescent ProteinsIBA 12/2015
1	carbonyl 3-chlorophenylhydrazoneIBA 12/2015
1	IonophoresIBA 12/2015
1	Monensin (Coban)IBA 12/2015
1	pyrazinoic acidIBA 12/2014

Therapy/Procedure

1	Therapeutics 10/2018